{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:06:16Z","timestamp":1779091576125,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PICTHS-2023\/100004"],"award-info":[{"award-number":["PICTHS-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PICTHS-2023\/100004"],"award-info":[{"award-number":["PICTHS-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PICTHS-2023\/100004"],"award-info":[{"award-number":["PICTHS-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PICTHS-2023\/100004"],"award-info":[{"award-number":["PICTHS-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PICTHS-2023\/100004"],"award-info":[{"award-number":["PICTHS-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PICTHS-2023\/100004"],"award-info":[{"award-number":["PICTHS-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PICTHS-2023\/100004"],"award-info":[{"award-number":["PICTHS-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PICTHS-2023\/100004"],"award-info":[{"award-number":["PICTHS-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PICTHS-2023\/100004"],"award-info":[{"award-number":["PICTHS-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PICTHS-2023\/100004"],"award-info":[{"award-number":["PICTHS-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PICTHS-2023\/100004"],"award-info":[{"award-number":["PICTHS-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PICTHS-2023\/100004"],"award-info":[{"award-number":["PICTHS-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,6,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Current BSG\/ACPGBI and NICE guidance recommends that faecal haemoglobin (f-Hb) \u226510\u2009ug\/g measured by faecal immunochemical test (FIT) in symptomatic patients should prompt referral through cancer prioritised diagnostic pathways. However, limited long term CRC outcome data exist. This study compared CRC specific survival (CSS) between patients by f-Hb concentration and referral priority in a large primary care f-Hb prioritised lower GI symptomatic pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective single health board study of symptomatic patients submitting FIT in primary care, 2019\u20132022. CRC diagnoses up to 3 years after pathway entry, and CRC deaths (ICD10 18, 19, 20) to end 2024 were recorded from cancer audit and MCN datasets. Patients were grouped by f-Hb concentration and referral priority. Univariable and multivariable Cox regression estimated CSS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Of 126,984 patients, 1453 (1%) were diagnosed with CRC within 3 years of f-Hb result or referral, of which 444 (31%) died due to CRC. At multivariable analysis, referral without FIT (HR 1.42, 95% CI 1.06\u20131.91), and f-Hb \u226510\u2009ug\/g diagnosed outwith CRC prioritised pathways (HR 1.47, 95% CI 1.03\u20132.10) were associated with worse CSS independent of TNM stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Referral and investigation through cancer prioritised pathways guided by f-Hb concentration is safe in relation to CSS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-026-03378-1","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:56:00Z","timestamp":1775116560000},"page":"1580-1591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Faecal haemoglobin-based referral and investigation prioritisation is associated with colorectal cancer-specific survival in symptomatic patients: a retrospective observational study"],"prefix":"10.1038","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5459-8445","authenticated-orcid":false,"given":"Stephen T.","family":"McSorley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Chantler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-1517","authenticated-orcid":false,"given":"Mark","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0661-7362","authenticated-orcid":false,"given":"Brian D.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"MacKay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Vella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanti","family":"Susanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Rigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Witherspoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"3378_CR1","unstructured":"Cancer Research UK. Early Diagnosis Hub. Routes to diagnosis. 2024 https:\/\/crukcancerintelligence.shinyapps.io\/EarlyDiagnosis\/. Accessed April 2025."},{"key":"3378_CR2","unstructured":"National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. NG12 2025 Update https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/1-Recommendations-organised-by-site-of-cancer#lower-gastrointestinal-tract-cancers. Accessed April 2025."},{"key":"3378_CR3","unstructured":"Healthcare Improvement Scotland: Right Decision Service. Scottish Referral Guidelines for Suspected Cancer. Lower Gastrointestinal Cancer. 2022 Update http:\/\/www.cancerreferral.scot.nhs.uk\/lower-gastrointestinal-cancer\/. Accessed April 2025."},{"key":"3378_CR4","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1111\/apt.18003","volume":"59","author":"D Beaton","year":"2024","unstructured":"Beaton D, Sharp L, Lu L, Trudgill N, Thoufeeq M, Nicholson B, et al. Diagnostic yield from symptomatic lower gastrointestinal endoscopy in the UK: a British Society of Gastroenterology analysis using data from the National Endoscopy Database. Aliment Pharmacol Ther. 2024;59:1589\u2013603. https:\/\/doi.org\/10.1111\/apt.18003.","journal-title":"Aliment Pharmacol Ther"},{"key":"3378_CR5","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/gutjnl-2015-309579","volume":"65","author":"C Mowat","year":"2016","unstructured":"Mowat C, Digby J, Strachan JA, Wilson R, Carey FA, Fraser CG, et al. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms. Gut. 2016;65:1463\u20139. https:\/\/doi.org\/10.1136\/gutjnl-2015-309579.","journal-title":"Gut"},{"key":"3378_CR6","unstructured":"National Institute for Health and Care Excellence. Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care. Diagnostics Guidance DG30 2017 https:\/\/www.nice.org.uk\/guidance\/dg30\/chapter\/1-Recommendations."},{"key":"3378_CR7","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1136\/gutjnl-2022-327985","volume":"71","author":"KJ Monahan","year":"2022","unstructured":"Monahan KJ, Davies MM, Abulafi M, Banerjea A, Nicholson BD, Arasaradnam R, et al. Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG). Gut. 2022;71:1939\u201362. https:\/\/doi.org\/10.1136\/gutjnl-2022-327985.","journal-title":"Gut"},{"key":"3378_CR8","unstructured":"National Institute for Health and Care Excellence. Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care. Diagnostics guidance DG56 2023 https:\/\/www.nice.org.uk\/guidance\/dg56. Accessed March 2025."},{"key":"3378_CR9","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/ijc.30639","volume":"140","author":"J Cubiella","year":"2017","unstructured":"Cubiella J, Digby J, Rodr\u00edguez-Alonso L, Vega P, Salve M, D\u00edaz-Ondina M, et al. COLONPREDICT study investigators. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients. Int J Cancer. 2017;140:2201\u201311. https:\/\/doi.org\/10.1002\/ijc.30639.","journal-title":"Int J Cancer."},{"key":"3378_CR10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/apt.18459","volume":"61","author":"CJ Crooks","year":"2025","unstructured":"Crooks CJ, West J, Jones J, Hamilton W, Bailey SER, Abel G, et al. COLOFIT Research Group; Humes DJ. COLOFIT: Development and Internal-External Validation of Models Using Age, Sex, Faecal Immunochemical and Blood Tests to Optimise Diagnosis of Colorectal Cancer in Symptomatic Patients. Aliment Pharmacol Ther. 2025;61:852\u201364. https:\/\/doi.org\/10.1111\/apt.18459.","journal-title":"Aliment Pharmacol Ther"},{"key":"3378_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/apt.17632","volume":"58","author":"CJ Crooks","year":"2023","unstructured":"Crooks CJ, Banerjea A, Jones J, Chapman C, Oliver S, West J, et al. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England. Aliment Pharmacol Ther. 2023;58:443\u201352. https:\/\/doi.org\/10.1111\/apt.17632.","journal-title":"Aliment Pharmacol Ther"},{"key":"3378_CR12","doi-asserted-by":"publisher","unstructured":"Digby J, Nobes J, Strachan JA, McCann R, Hall C, Fraser CG, et al. Combining faecal haemoglobin, iron deficiency anaemia status and age can improve colorectal cancer risk prediction in patients attending primary care with bowel symptoms: a retrospective observational study. Gut. 2025 Mar:gutjnl-2024-334248. https:\/\/doi.org\/10.1136\/gutjnl-2024-334248.","DOI":"10.1136\/gutjnl-2024-334248"},{"key":"3378_CR13","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/codi.16240","volume":"24","author":"MS Johnstone","year":"2022","unstructured":"Johnstone MS, MacLeod C, Digby J, Al-Azzawi Y, Pang G, Watson AJM, et al. Prevalence of repeat faecal immunochemical testing in symptomatic patients attending primary care. Colorectal Dis. 2022;24:1498\u2013504. https:\/\/doi.org\/10.1111\/codi.16240.","journal-title":"Colorectal Dis"},{"key":"3378_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/bjs\/znad016","volume":"110","author":"AD Gerrard","year":"2023","unstructured":"Gerrard AD, Maeda Y, Miller J, Gunn F, Theodoratou E, Noble C, et al. Edinburgh Colorectal Group. Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer. Br J Surg. 2023;110:471\u201380. https:\/\/doi.org\/10.1093\/bjs\/znad016.","journal-title":"Br J Surg"},{"key":"3378_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/codi.70024","volume":"27","author":"J Lucocq","year":"2025","unstructured":"Lucocq J, Barron E, Holmes H, Donnelly PD, Cruickshank N. Diagnostic accuracy of quantitative faecal immunochemical test in symptomatic patients for the investigation of colorectal cancer once accounting for anaemia severity and iron deficiency. Colorectal Dis. 2025;27:e70024. https:\/\/doi.org\/10.1111\/codi.70024. PMID: 39920888.","journal-title":"Colorectal Dis"},{"key":"3378_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100518","volume":"23","author":"R Booth","year":"2022","unstructured":"Booth R, Carten R, D\u2019Souza N, Westwood M, Kleijnen J, Abulafi M. Role of the faecal immunochemical test in patients with risk-stratified suspected colorectal cancer symptoms: A systematic review and meta-analysis to inform the ACPGBI\/BSG guidelines. Lancet Reg Health Eur. 2022;23:100518. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100518.","journal-title":"Lancet Reg Health Eur"},{"key":"3378_CR17","doi-asserted-by":"publisher","unstructured":"McSorley ST, Digby J, Clyde D, Cruickshank N, Burton P, Barker L, et al. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care. Colorectal Dis. 2020. https:\/\/doi.org\/10.1111\/codi.15405.","DOI":"10.1111\/codi.15405"},{"key":"3378_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00384-021-04079-2","volume":"37","author":"MS Johnstone","year":"2022","unstructured":"Johnstone MS, Burton P, Kourounis G, Winter J, Crighton E, Mansouri D, et al. Combining the quantitative faecal immunochemical test and full blood count reliably rules out colorectal cancer in a symptomatic patient referral pathway. Int J Colorectal Dis. 2022;37:457\u201366. https:\/\/doi.org\/10.1007\/s00384-021-04079-2.","journal-title":"Int J Colorectal Dis"},{"key":"3378_CR19","unstructured":"World Health Organisation. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutritional Information System. World Health Organisation, Geneva 2011 WHO\/NMH\/NHD\/MNM\/111)."},{"key":"3378_CR20","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/bjc.2012.68","volume":"106","author":"D Weller","year":"2012","unstructured":"Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106:1262\u20137. https:\/\/doi.org\/10.1038\/bjc.2012.68.","journal-title":"Br J Cancer"},{"key":"3378_CR21","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/apt.18208","volume":"60","author":"FL Malcolm","year":"2024","unstructured":"Malcolm FL, Yapa AKDS, Wong ZY, Morton AJ, Crooks C, West J, et al. Systematic review: Mortality associated with raised faecal immunochemical test and positive faecal occult blood results. Aliment Pharmacol Ther. 2024;60:840\u201354. https:\/\/doi.org\/10.1111\/apt.18208.","journal-title":"Aliment Pharmacol Ther"},{"key":"3378_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07074-y","volume":"20","author":"MA Gutierrez-Stampa","year":"2020","unstructured":"Gutierrez-Stampa MA, Aguilar V, Sarasqueta C, Cubiella J, Portillo I, Bujanda L. Impact of the faecal immunochemical test on colorectal cancer survival. BMC Cancer. 2020;20:616. https:\/\/doi.org\/10.1186\/s12885-020-07074-y.","journal-title":"BMC Cancer"},{"key":"3378_CR23","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3390\/diagnostics12041013","volume":"12","author":"JD Fern\u00e1ndez de Castro","year":"2022","unstructured":"Fern\u00e1ndez de Castro JD, Baiocchi Ureta F, Fern\u00e1ndez Gonz\u00e1lez R, Pin Vieito N, Cubiella Fern\u00e1ndez J. Faecal Immunochemical Test Impact on Prognosis of Colorectal Cancer Detected in Symptomatic Patients. Diagnostics. 2022;12:1013 https:\/\/doi.org\/10.3390\/diagnostics12041013.","journal-title":"Diagnostics"},{"key":"3378_CR24","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/codi.16451","volume":"25","author":"D Delson","year":"2023","unstructured":"Delson D, Ward M, Haddock R, Nobes J, Digby J, Strachan JA, et al. Impact of faecal haemoglobin-based triage of bowel symptoms presenting to primary care on colorectal cancer diagnosis. Colorectal Dis. 2023;25:787\u201393. https:\/\/doi.org\/10.1111\/codi.16451.","journal-title":"Colorectal Dis"},{"key":"3378_CR25","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1111\/codi.17083","volume":"26","author":"GK Atwal","year":"2024","unstructured":"Atwal GK, Digby J, Nobes J, Strachan J, Mowat C. The impact of primary-care led, faecal immunochemical test-based, triage of new-onset colorectal symptoms on time to diagnosis of colorectal cancer\u2014an observational study. Colorectal Dis. 2024;26:1544\u201350. https:\/\/doi.org\/10.1111\/codi.17083.","journal-title":"Colorectal Dis"},{"key":"3378_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2023.101842","volume":"66","author":"W Hamilton","year":"2023","unstructured":"Hamilton W, Bailey SER. Colorectal cancer in symptomatic patients: how to improve the diagnostic pathway. Best Prac Res Clin Gastroenterol. 2023;66:101842.","journal-title":"Best Prac Res Clin Gastroenterol"},{"key":"3378_CR27","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1038\/bjc.2015.48","volume":"112","author":"RD Neal","year":"2015","unstructured":"Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112:S92\u2013107. https:\/\/doi.org\/10.1038\/bjc.2015.48.","journal-title":"Br J Cancer"},{"key":"3378_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102204","volume":"64","author":"JS Hampton","year":"2023","unstructured":"Hampton JS, Kenny RPW, Rees CJ, Hamilton W, Eastaugh C, Richmond C, et al. COLOFIT Research Team. The performance of FIT-based and other risk prediction models for colorectal neoplasia in symptomatic patients: a systematic review. EClinicalMedicine. 2023;64. 102204. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102204.","journal-title":"EClinicalMedicine"},{"key":"3378_CR29","unstructured":"Cancer Research UK. Test Evidence Transition\u2014Programme Handout. 2024 https:\/\/www.cancerresearchuk.org\/sites\/default\/files\/tet_programme_overview_2024_0.pdf. Accessed May 2025."},{"key":"3378_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/jep.14120","volume":"31","author":"S Hamer-Kiwacz","year":"2025","unstructured":"Hamer-Kiwacz S, Berntsson H, Galloway G, Tran AM, Tan JY, Hind D, et al. Barriers and facilitators to faecal immunochemical testing in symptomatic populations: A rapid systematic scoping review and gap analysis. J Eval Clin Pract. 2025;31:e14120. https:\/\/doi.org\/10.1111\/jep.14120.","journal-title":"J Eval Clin Pract"},{"key":"3378_CR31","doi-asserted-by":"publisher","first-page":"e843","DOI":"10.3399\/BJGP.2023.0033","volume":"73","author":"JA Bailey","year":"2023","unstructured":"Bailey JA, Morton AJ, Jones J, Chapman CJ, Oliver Smorling JR, et al. Sociodemographic variations in the uptake of faecal immunochemical tests in primary care: a retrospective study. Br J Gen Pract. 2023;73:e843\u2013e9.","journal-title":"Br J Gen Pract"},{"key":"3378_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/bjs\/znad036","volume":"110","author":"P Cripps","year":"2023","unstructured":"Cripps P, Scott K, Sekhar H, Harries RL, Taylor GW. Faecal immunochemical testing in symptomatic lower gastrointestinal triage: cohort study of patient acceptability and impact of social deprivation. Br J Surg. 2023;110:511\u20132. https:\/\/doi.org\/10.1093\/bjs\/znad036.","journal-title":"Br J Surg"},{"key":"3378_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/epirev\/mxq018","volume":"33","author":"C von Wagner","year":"2011","unstructured":"von Wagner C, Good A, Whitaker KL, Wardle J. Psychosocial determinants of socioeconomic inequalities in cancer screening participation: a conceptual framework. Epidemiol Rev. 2011;33:135\u201347.","journal-title":"Epidemiol Rev"},{"key":"3378_CR34","unstructured":"Deprivation: Understanding Glasgow: The Glasgow Indicators Project; [accessed 2025 5th December] Available from: https:\/\/www.understandingglasgow.com\/indicators\/poverty\/deprivation."},{"key":"3378_CR35","unstructured":"Scottish bowel screening programme statistics: Public Health Scotland; 2023 [Accessed 2025 5th December]. Available from: https:\/\/publichealthscotland.scot\/publications\/scottishbowel-screening-programme-statistics\/scottish-bowel-screening-programme-statistics-forthe-period-of-invitations-from-may-2020-to-april-2022\/."},{"key":"3378_CR36","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/pubmed\/fdad179","volume":"45","author":"A Creavin","year":"2023","unstructured":"Creavin A, Creavin S, Kenward C, Sterne J, Williams J. Inequality in uptake of bowel cancer screening by deprivation, ethnicity and smoking status: cross-sectional study in 86 850 citizens. J Public Health. 2023;45:904\u201311.","journal-title":"J Public Health"},{"key":"3378_CR37","unstructured":"Healthcare Improvement Scotland, Right Decision Service. Scottish referral guidelines for suspected cancer, Lower gastrointestinal cancers. https:\/\/rightdecisions.scot.nhs.uk\/shared-content\/cfsd-modernising-patient-pathways\/scottish-referral-guidelines-for-suspected-cancer\/lower-gastrointestinal-cancers\/. Accessed 12 August 2025."},{"key":"3378_CR38","unstructured":"NHS Scotland, Centre for Sustainable Delivery. Quantitative Faecal Immunohistochemical Testing qFIT. 2024 https:\/\/www.nhscfsd.co.uk\/media\/hifbxk0i\/quantitative-faecal-immunohistochemical-testing-2024-v6.pdf. Accessed 12 August 2025."},{"key":"3378_CR39","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/apt.15969","volume":"52","author":"BD Nicholson","year":"2020","unstructured":"Nicholson BD, James T, Paddon M, Justice S, Oke JL, East JE, et al. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests. Aliment Pharmacol Ther. 2020;52:1031\u201341. https:\/\/doi.org\/10.1111\/apt.15969.","journal-title":"Aliment Pharmacol Ther"},{"key":"3378_CR40","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41416-020-01221-9","volume":"124","author":"SER Bailey","year":"2021","unstructured":"Bailey SER, Abel GA, Atkins A, Byford R, Davies SJ, Mays J, et al. Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England. Br J Cancer. 2021;124:1231\u20136. https:\/\/doi.org\/10.1038\/s41416-020-01221-9.","journal-title":"Br J Cancer"},{"key":"3378_CR41","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1136\/gutjnl-2020-321956","volume":"70","author":"N D\u2019Souza","year":"2021","unstructured":"D\u2019Souza N, Georgiou Delisle T, Chen M, Benton S, Abulafi M, NICE FIT Steering Group, et al. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study. Gut. 2021;70:1130\u20138.","journal-title":"Gut"},{"key":"3378_CR42","doi-asserted-by":"publisher","first-page":"l6090","DOI":"10.1136\/bmj.l6090","volume":"367","author":"NE Burr","year":"2019","unstructured":"Burr NE, Derbyshire E, Taylor J, Whalley S, Subramanian V, Finan PJ, et al. Variation in post-colonoscopy colorectal cancer across colonoscopy providers in English National Health Service: population-based cohort study. BMJ. 2019;367:l6090 https:\/\/doi.org\/10.1136\/bmj.l6090.","journal-title":"BMJ"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03378-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03378-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03378-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:07:29Z","timestamp":1779088049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03378-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,6,5]]}},"alternative-id":["3378"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03378-1","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocol and results of this study were presented to the Glasgow Colorectal PPIE group. The authors thank the group members for their contribution to the wording and emphasis of the reporting and their ongoing help with dissemination. Dr Susanti Susanti, one of the co-authors of this paper is a PPIE representative within the CRUK TET project and the Glasgow Colorectal PPIE group with lived experience of treatment for colorectal cancer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}}]}}